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Abstract
Background: Current research implicates interleukin (IL)-6 as a key component of the nervous-system response to
injury with various effects.
Methods: We used unilateral chronic constriction injury (CCI) of rat sciatic nerve as a model for neuropathic pain.
Immunofluorescence, ELISA, western blotting and in situ hybridization were used to investigate bilateral changes in
IL-6 protein and mRNA in both lumbar (L4-L5) and cervical (C7-C8) dorsal root ganglia (DRG) following CCI. The
operated (CCI) and sham-operated (sham) rats were assessed after 1, 3, 7, and 14 days. Withdrawal thresholds for
mechanical hyperalgesia and latencies for thermal hyperalgesia were measured in both ipsilateral and contralateral
hind and fore paws.
Results: The ipsilateral hind paws of all CCI rats displayed a decreased threshold of mechanical hyperalgesia and
withdrawal latency of thermal hyperalgesia, while the contralateral hind and fore paws of both sides exhibited no
significant changes in mechanical or thermal sensitivity. No significant behavioral changes were found in the hind
and fore paws on either side of the sham rats, except for thermal hypersensitivity, which was present bilaterally at 3
days. Unilateral CCI of the sciatic nerve induced a bilateral increase in IL-6 immunostaining in the neuronal bodies
and satellite glial cells (SGC) surrounding neurons of both lumbar and cervical DRG, compared with those of naive
control rats. This bilateral increase in IL-6 protein levels was confirmed by ELISA and western blotting. More intense
staining for IL-6 mRNA was detected in lumbar and cervical DRG from both sides of rats following CCI. The DRG
removed from sham rats displayed a similar pattern of staining for IL-6 protein and mRNA as found in naive DRG,
but there was a higher staining intensity in SGC.
Conclusions: Bilateral elevation of IL-6 protein and mRNA is not limited to DRG homonymous to the injured nerve,
but also extended to DRG that are heteronymous to the injured nerve. The results for IL-6 suggest that the
neuroinflammatory reaction of DRG to nerve injury is propagated alongside the neuroaxis from the lumbar to the
remote cervical segments. This is probably related to conditioning of cervical DRG neurons to injury.
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Background
Neuropathic pain has recently been defined as ‘pain aris-
ing as a direct consequence of a lesion or disease affecting
the somatosensory system’ [1] and is therefore not directly
associated with nociceptive input. Peripheral neuropathic
pain, manifested as spontaneous pain and hyperalgesia,
arises as a result of various forms of peripheral nerve
damage, such as traumatic nerve injury, or neuropathy as-
sociated with diabetes or HIV infection [2,3].
There is compelling evidence indicating that hyperalgesia
and ongoing pain due to peripheral nerve injury are associ-
ated with excitability of [4] and cellular and molecular
changes in dorsal root ganglia (DRG), including prolifera-
tion and activation of satellite glial cells (SGC) [5], invasion
of macrophages [6], and upregulation and downregulation
of genes and proteins [7,8].
Pro-inflammatory and anti-inflammatory cytokines
contribute to both induction and maintenance of neuro-
pathic pain derived from cellular and molecular changes
in the DRG [9,10]. Interleukin (IL)-6 is a member of the
family of cytokines collectively termed ‘the interleukin-6-
type cytokines’, which have diverse functions throughout
the body. A growing body of evidence implicates IL-6 as
a key component in the response of the nervous system
to injury. For example, IL-6 is involved in promoting
neuronal survival and protection against neuronal damage
[11,12] and also in modulating pain [13,14].
In response to sciatic nerve transection, IL-6 protein
and mRNA levels were found to be raised in medium to
large sensory neurons 2 to 4 days after such damage in the
ipsilateral, but not the contralateral, DRG homonymous
to the injured nerve. By contrast, a nerve-constriction
model induced lower concentrations of IL-6 protein and
mRNA in DRG neurons, but both persisted longer than in
a nerve-transection model. Presence of IL-6 in the nerve-
constriction model of neuropathic pain correlated well
with the duration of hypersensitivity [15,16].
A growing body of evidence indicates that unilateral
nerve injury results in bilateral cellular and molecular
changes in the nerve structures [17,18], and in bilateral
changes indicated by behavioral tests [19]. In addition,
neighboring uninjured DRG display changes after lesion
of non-associated nerves [20,21].
The aim of the present study was to investigate quan-
titative alterations in IL-6 protein and mRNA levels fol-
lowing unilateral chronic constriction injury (CCI) of the
sciatic nerve in both ipsilateral and contralateral DRG at
L4-L5 and C7-C8 levels.
Methods
Animals and surgical procedures
Procedures were performed in accordance with proto-
cols approved by the Animal Investigation Committee of
the Faculty of Medicine, Brno, Czech Republic, and
followed ethical guidance [22].
All experimental procedures were carried out under
sterile conditions by the same person. The experiments
were performed using 159 adult male Wistar rats 250–300
g in weight (Anlab, Brno, Czech Republic). The animals
were housed on a 12 hour light/12 hour dark cycle at a
temperature of 22 to 24°C, under specific pathogen-free
conditions in the animal housing facility of Masaryk
University. Sterilized standard rodent food and water were
available ad libitum.
Surgical procedures were performed under deep anesthesia
with a mixture of equal volumes of intraperitoneal (IP) keta-
mine 40 mg/ml and xylazine 4 mg/ml (Bioveta a.s., Czech
Republic) (0.2 ml/100 g body weight). To prepare the unilat-
eral CCI, the right sciatic nerve was exposed at mid-thigh
level by blunt dissection just proximal to its trifurcation, and
three ligatures (3-0 sutures; Johnson&Johnson, Ethicon, Inc.,
Belgium) were applied to reduce the nerve diameter by one-
third. Animals who underwent CCI were left to survive for 1
(n = 21), 3 (n = 21), 7 (n = 21), or 14 (n = 21) days. The
naïve control group consisted of 21 intact rats. Sham-
operated rats (sham group; n = 54) had the right sciatic
nerves exposed only, without lesion, and were allowed to
survive for 1 (n = 21), 3 (n = 21), and 14 (n = 12) days. The
assessors of the experimental groups were blinded to treat-
ment (CCI versus sham) for all types of measurement.
Behavioral tests
Withdrawal thresholds for mechanical hyperalgesia and
latencies for thermal hyperalgesia were measured in both
ipsilateral and contralateral hind and forepaws by
dynamic plantar esthesiometer and plantar test (Ugo
Basile, Italy), respectively. Rats were first acclimated in
clear Plexiglas boxes for 30 minutes prior to testing. The
paws were tested alternately with a 5 minute interval be-
tween tests. Six threshold and six latency measurements
were taken for each paw during each test session 1 day
before and 1, 3, 7, and 14 days after operation.
For thermal hyperalgesia, withdrawal time was mea-
sured and the intensity radiance was set to a value of 50.
Data are expressed as mean ± SD of withdrawal thresh-
olds (grams) and withdrawal latencies (seconds) for
mechanical and thermal hyperalgesia, respectively.
Immunohistochemical staining
Three naive rats and three rats for each period of sur-
vival from CCI (1, 3, 7, and 14 days) and sham operation
(1, 3, and 14 days) were deeply anesthetized with a lethal
dose of sodium pentobarbital (70 mg/kg body weight,
IP) and perfused transcardially with 500 ml phosphate-
buffered saline (PBS: 10 mmol/l sodium phosphate buf-
fer, pH 7.4, containing 0.15 mol/l NaCl) followed by 500
ml of Zamboni’s fixative [23]. The L4-L5 and C7-C8
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DRG from both sides were detected within their
intervertebral foramina after total laminectomy and
foraminotomy. The DRG were removed, immersed sep-
arately in Zamboni’s fixative at 4°C overnight, and then
collected separately into samples of ipsilateral lumbar
(L-DRGi), contralateral lumbar (L-DRGc), ipsilateral cer-
vical (C-DRGi) and contralateral cervical (C-DRGc)
DRG for each period of survival and each group of rats
(naive, sham, and CCI). The samples were washed in
20% phosphate-buffered sucrose for 12 hours. Pairs of
ipsilateral and contralateral DRG (C7-C8 or L4-L5 seg-
ments) were embedded in optimal cutting temperature
compound (Tissue-Tek® OCT compound; Miles, Elkhart,
IN USA) and cut together. Serial longitudinal cryostat
sections (12 μm) through the DRG were mounted on
chrome-alum coated slides, and processed for indirect
immunohistochemical staining, which was performed
simultaneously for lumbar and cervical segments.
Interleukin-6 and interleukin-6 receptor immuno-
fluorescence. Sections were washed with PBS containing
0.05% Tween 20 (PBS-T) and 1% bovine serum albumin
(BSA) for 10 minutes, treated with 5% normal donkey
serum in PBS-T for 30 minutes, then incubated with 25
μl of rabbit polyclonal antibodies against IL-6 (1:500;
Invitrogen Inc., Camarillo, CA, USA) or IL-6R (1:200;
Santa Cruz Biotechnology, Santa Cruz, CA, USA) in a
humid chamber at room temperature (21 to 23°C) for 12
hours. The immunohistochemical reaction was visual-
ized by treatment with tetramethyl rhodamine iso-
thiocyanate (TRITC)-conjugated and affinity-purified
donkey anti-rabbit secondary antibody (1:100; Millipor,
Billerica, MA, USA) for 90 minutes at room temperature.
The control sections were incubated without the primary
antibody or with the primary antibody saturated by recom-
binant rat IL-6 protein (Invitrogen). Sections were stained
with Hoechst 33342 to detect positions of the cell nuclei,
mounted in aqueous mounting medium (Vectashield;
Vector Laboratories Inc., Burlingame, CA, USA) and ana-
lyzed using an epifluorescence microscope (DMLB; Leica
Microsystems GmbH, Wetzlar Germany) equipped with a
camera (DFC-480; Leica Microsystems) and a stabilized
power supply for the lamp housing. The same immuno-
staining pattern for IL-6 and interleukin-6 receptor (IL-6R)
was seen in the DRG of L4-L5 and of C7-C8 spinal-cord
segments removed from the same side of naive, CCI and
sham rats. Therefore, the results are described for the lum-
bar or cervical DRG of the ipsilateral or contralateral side.
Double immunostaining. Some of the sections taken
through ipsilateral lumbar DRG from CCI rats surviving
for 3 or 7 days were double-stained. After incubation
with rabbit polyclonal anti–IL-6 antibody for 12 hours
and intensive washing, the sections were covered with
mouse monoclonal anti-glutamine synthase (anti-GS;
1:500; LS-C23895; LifeSpan BioSciences, Inc., Seattle,
WA, USA), anti-CD68 (ED-1; 1:100; MCA341R) or anti-T-
cell receptor (anti-TCR; 1:50; MCA453G) (both Serotec,
Düsseldorf, Germany) antibodies and incubated for 4 hours.
A mixture (1:1) of affinity-purified TRITC-conjugated
donkey anti-rabbit and fluorescein isothiocyanate (FITC)-
conjugated donkey anti-mouse secondary antibodies
(Millipor, Billerica, MA, USA) was applied at a final
dilution of 1:100 for 90 minutes at room temperature.
To visualize colocalization of IL-6 and activating tran-
scription factor (ATF-3) indicating neuronal bodies with
injured axons [24], the sections were incubated with mono-
clonal anti-IL-6 antibody (1:100; ARC0962; BioSource,
Camarillo, CA, USA) and then rabbit polyclonal anti-ATF3
(1:200; sc188; Santa Cruz Biotechnology, Santa Cruz, CA,
USA). After intensive washing, affinity-purified TRITC-
conjugated donkey anti-mouse and FITC-conjugated don-
key anti-rabbit secondary antibodies (Millipor, Billerica, MA,
USA) were applied at a final dilution of 1:100 for 90 minutes
at room temperature.
Sections incubated with rabbit polyclonal anti-IL-6R anti-
body for 12 hours were then treated with mouse monoclo-
nal anti-GS for 4 hours. To visualize colocalization, the
sections were incubated with TRITC-conjugated donkey
anti-rabbit and FITC-conjugated donkey anti-mouse sec-
ondary antibodies at room temperature for 90 minutes.
ELISA
Six naive rats and, CCI rats surviving for 1 (n = 6), 3 (n = 6),
7 (n = 6), and 14 (n = 6) days, and sham rats surviving for 1
(n = 6), 3 (n = 6), and 14 (n = 6) days were killed by CO2 in-
halation. Blood samples were obtained by intracardiac punc-
ture, and collected into tubes containing heparin and
protease inhibitor cocktail (LaRoche, Basel, Switzerland).
Plasma was immediately separated by low-speed centrifuga-
tion (2,500 g for 12 minutes).
Both ipsilateral and contralateral L4-L5 and C6-C7
DRG were removed and immediately collected in ice-
cold PBS-T containing protease inhibitor cocktail
(LaRoche, Basel, Switzerland). The DRG samples were
divided into distinct groups of lumbar and cervical naive
DRG (C-DRGn, L-DRGn) and ipsilateral and contralat-
eral lumbar and cervical DRG (L-DRGi, L-DRGc, C-
DRGi, and C-DRGc) taken from both CCI and sham rats
for each period of survival. The DRG samples were ho-
mogenized in ice-cold PBS-T and separated by centrifu-
gation (12,500 g for 12 minutes) to obtain extract
proteins.
The tissue supernatant and plasma samples were
stored at −60°C until analyzed. The total protein concen-
tration was measured by spectrophotometer (Nanodrop
ND-1000; Thermo Fisher Scientific Inc., Rockford, IL,
USA) and the level of IL-6 protein was assessed by
ELISA using a commercial kit with a sensitivity of 5 pg/
ml (BioSource, Camarillo, CA, USA) in accordance with
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the manufacturer’s instructions. Each sample was mea-
sured five times using a microplate reader (SUNRISE
Basic; Tecan, Salzburg, Austria) and data were standard-
ized as pg of IL-6 protein to 100 μg of total protein. The
IL-6 protein levels were normalized to baseline values of
DRG and plasma from naive rats, which were set as 1,
and final data are expressed as mean ± SD.
Western blotting analysis
Naive rats (n = 6), CCI rats surviving for 1 (n = 6), 3 (n = 6),
7 (n = 6), and 14 (n = 6) days, and sham rats surviving for 1
(n = 6) or 3 (n = 6) days were deeply anesthetized with a le-
thal dose of sodium pentobarbital (70 mg/kg body weight,
IP.). DRG of both sides were then detected within their
intervertebral foramina after total laminectomy and
foraminotomy. Whole DRG were extracted under aseptic
conditions from L4-L5 and C7-C8 levels, and classified as
ipsilateral lumbar (L-DRGi), contralateral lumbar (L-DRGc),
ipsilateral cervical (C-DRGi), and contralateral cervical (C-
DRGc) DRG for each period of survival and each group of
rats (naive, CCI, and sham). These were fast-frozen in liquid
nitrogen, then stored at −65°C until the time of analysis. For
triplicate western blotting analysis, samples of DRG were
collected from two rats in each group. The samples were
homogenized in PBS containing 0.1% Triton X-100 and pro-
tease inhibitors (LaRoche) and separated by centrifugation
at 10,000 g for 5 minutes at 4°C. The total protein concen-
tration was measured in the tissue supernatant (Nanodrop
ND-1000; Thermo Fisher Scientific) and normalized to the
same levels. Proteins were separated by SDS-polyacrylamide
gel electrophoresis [25] and transferred to nitrocellulose
membranes by electroblotting (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA). Blots were blocked by 1% BSA in PBS-
T (3.2 mmol/l Na2HPO4, 0.5 mmol/l KH2PO4, 1.3 mmol/l
KCl, 135 mmol/l NaCl, 0.05% Tween 20, pH 7.4) for 1 hours
and incubated with anti-IL-6 polyclonal antibody (1:500;
ARC0062; Biosource) overnight. Blots were washed in PBS-
T and incubated with peroxidase-conjugated anti-rabbit IgG
(1:1000; Sigma-Aldrich, St Louis, MO, USA) for 1 hour at
room temperature. Equal loading of proteins was confirmed
by α-tubulin staining. Protein bands were visualized using a
chemiluminescence detection kit (ECL kit; Amersham Bio-
sciences Inc., Piscataway, NJ, USA) on a chemiluminometer
reader (LAS-3000; Bouchet Biotech) and analyzed using
densitometry image software. After normalization to tubulin,
IL-6 protein data were expressed as mean fold change rela-
tive to naive DRG, which was set as 1.
In situ hybridization
For DRG tissue harvesting, three naive rats and three
rats for each period of survival were deeply anesthetized
with a lethal dose of sodium pentobarbital (70 mg/kg
body weight, IP), and perfused transcardially with 500
ml PBS containing 0.1% diethylpyrocarbonate (DEPC),
followed by 500 ml of 4% paraformaldehyde with 0.1%
DEPC. The DRG samples were washed in 20% phosphate-
buffered sucrose for 12 hours and embedded in OCT
compound (Tissue-Tek®; Miles). Serial longitudinal sec-
tions 12 μm thick through the DRG were cut on a cryostat
and then mounted on chrome-alum coated slides.
To localize the IL-6 gene transcript, in situ hybridization
was performed in accordance with the protocol of
Harnicarova and coworkers [26]. We used two 50-mer
oligoprobes (VBC-Biotech, Vienna, Austria) synthesized
for the target IL-6 gene transcript (Table 1). Digoxigenin
(DIG)-dT was used for probe labeling. All solutions used
in this procedure were prepared in double-distilled water
treated with DEPC. DIG was detected with a commercial
kit (DIG Colorimetric Nucleic Acid Detection Kit;
LaRoche). The sections were mounted in aqueous mount-
ing medium (Vectashield; Vector Laboratories) and ana-
lyzed using a microscope (DMLB; Leica Microsystems)
equipped with a camera (DFC-480; Leica Microsystems).
The control sections that had been incubated without the
DIG-oligonucleotide probes displayed no color staining.
Image analysis
The neuronal diameter, immunofluorescence intensity
(brightness), and density of mRNA staining were
assessed using an image analysis system (LUCIA-G; La-
boratory Imaging Ltd., Prague, Czech Republic) in ac-
cordance with our previously published protocol [27].
Briefly, stained structures were detected for measure-
ment after subtraction of background by the interactive
thresholding technique (HSI: hue, saturation, and inten-
sity) implemented in the image analysis (LUCIA) soft-
ware, then transformed to binary mode. The binary
foreground was monitored at every step of thresholding
and manually edited if needed. The original color image
was converted to gray and overlaid with the binary map.
At least 200 neuronal profiles containing nuclei were
measured for short (1 and 3 days) and late (7 and 14
days) periods of survival. The diameters of the DRG
neurons were calculated from areas of neuronal profiles
in sections for immunofluorescence and in situ hybridization,
and the sizes of the DRG neurons were categorized as
small (<25 μm), medium (25–40 μm), or large (>40 μm).
The immunofluorescence and mRNA staining intensities
were normalized to values of naive DRG and expressed as
mean fold increase of intensity ± SD.
Statistical analyses
Behavioral data were evaluated using Kruskal-Wallis
one-way analysis with Bonferroni post hoc test and
P<0.05 was considered significant. To verify differences
in ELISA, a Bonferroni-corrected one-way ANOVA for
repeated measures was run, with P<0.05 as the level of
significant difference between tested samples. Data for
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naive and CCI rats for intensity of IL-6 and IL-6R im-
munostaining and density of IL-6 mRNA were tested
using the Mann-Whitney U-test (P<0.05). All statistical
analyses were performed using STATISTICA software
(version 9.0; StatSoft Inc., Tulsa, OK, USA).
Results
Behavioral tests
All rats with CCI of the sciatic nerve displayed de-
creased thresholds of mechanical hyperalgesia and with-
drawal latencies of thermal hyperalgesia restricted to the
hind paws ipsilateral to nerve ligatures as signs of neuro-
pathic pain. There were no significant changes in
withdrawal threshold for mechanical and thermal
hyperalgesia in the contralateral hind paws compared
with the results 1 day before operation. Thresholds of
mechanical and thermal hyperalgesia did not signifi-
cantly change in either the ipsilateral or contralateral
fore paws (Figure 1A).
Both ipsilateral and contralateral hind paws of sham
rats exhibited a decrease in thresholds of mechanical
hyperalgesia between days 3 and 14, but there was no




Asterisks indicate position of digoxigenin labeling.
Figure 1 Results of behavioral test. (A) Results of behavioral tests in rats operated upon to create unilateral chronic constriction injury (CCI) of
the sciatic nerve and (B) in sham-operated rats. Progressive development of evoked mechanical and thermal hyperalgesia was found in the
ipsilateral hind paws of CCI rats. Transient thermal hyperalgesia was present bilaterally in both hind and fore paws 3 days after the sham
operation. Data are expressed as mean ± SD of withdrawal thresholds (grams) and withdrawal latency (seconds) of mechanical and thermal
hyperalgesia, respectively. Symbols identical to graph lines indicate significant differences (P<0.05) compared with measurements taken 1 day
before operation.
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statistical significance when compared with 1 day before
surgical treatment. By contrast, significantly decreased
withdrawal latencies of thermal hyperalgesia were found
1 and 3 days after the sham operation. This bilateral
hypersensitivity for thermal stimuli was present in both
fore and hind paws, and normalized during the following
days of survival after the sham operation (Figure 1B).
Immunohistochemical staining
Interleukin-6 immunofluorescence
Sections of lumbar and cervical DRG from naive rats
showed weak immunofluorescence staining for IL-6 pro-
tein in small and medium-sized neuronal bodies and in
SGC enveloping large neuronal bodies (Figure 2A,B). An
increased intensity of IL-6 immunofluorescence was in-
duced in all neuronal types of both ipsilateral and
contralateral DRG removed from lumbar and cervical
levels of all rats surviving up to 14 days after unilateral
CCI of the sciatic nerve. A distinct increase in immuno-
fluorescence intensity was particularly apparent in large
neuronal bodies (>40 μm) compared with DRG removed
from naive rats. The sections of lumbar and cervical
DRG obtained from sham rats displayed a similar pat-
tern and intensity of IL-6 immunofluorescence staining
in the neuronal bodies to those removed from naive rats.
In contrast to naive DRG, however, moderate intensity
of IL-6 immunostaining was seen in SGC. Representative
immunostaining for IL-6 in sections of lumbar and cer-
vical DRG removed from both sides of rats surviving 3
days after CCI and sham operations is shown in Figure 2.
The control sections of DRG from CCI rats incubated
with omission of the primary antibody or with the pri-
mary antibody saturated with protein were free of im-
munofluorescence staining (data not shown).
Immunofluorescence for ATF-3, indicating neuronal
bodies with injured axons [24], was found in neuronal
nuclei of lumbar DRG ipsilateral to CCI but not in cer-
vical DRG. Only a few neurons of contralateral lumbar
DRG displayed ATF-3 immunostaining. The increased
IL-6 immunoreactivity in ipsilateral lumbar DRG was
present not only in ATF-3-positive but also in ATF-3-
free neurons (Figure 3A–C). Double immunostaining
also confirmed an increase in IL-6 protein in SGC
(Figure 3D–F), and provided evidence of a contribution
of ED-1+ macrophages and TCR+ cells to the IL-6 level
in DRG removed from rats subjected to CCI (Figure 4).
Compared with naive DRG, a significant increase in
IL-6 immunofluorescence intensity was detected in
large, medium, and small neuronal bodies of both
lumbar and cervical DRG from rats surviving for short
(3 days) and long (14 days) periods after CCI treatment.
The highest increase in IL-6 intensity was found in large
neurons of lumbar DRG ipsilateral to CCI, and this level
was significantly higher than the contralateral counterpart.
However, the large neurons of cervical DRG and the
medium and small neurons of both cervical and lumbar
DRG displayed increased immunofluorescence intensity
without significant differences when the ipsilateral and
contralateral sides were compared in each period of sur-
vival. The IL-6 intensity of large neurons of ipsilateral lum-
bar DRG was significantly reduced when we compared
short and long periods of survival, whereas a bilateral de-
crease was found in medium neurons for the same com-
parison. Small neurons in lumbar DRG and all types of
neurons in cervical DRG did not display significant changes
when short and long periods were compared (Figure 5).
Interleukin-6 receptor immunofluorescence
Sections of naive lumbar and cervical DRG displayed IL-
6R immunofluorescence of moderate intensity in me-
dium and small neurons, whereas large neuronal bodies
had very weak or no immunostaining. Compared with
naive DRG, there was a significant increase in IL-6R im-
munofluorescence bilaterally in all neurons of lumbar
DRG from CCI rats for short (3 days) and long (14 days)
periods of survival. Distinct immunofluorescence was
also present in SGC, surrounding mainly large neurons
of ipsilateral lumbar DRG (Figure 6). This was con-
firmed by double immunostaining for IL-6R and with
GS used as a marker for SGC (Figure 7). There was a
significantly increased intensity of IL-6R immunostain-
ing in the neuronal bodies of all diameters in both lum-
bar and cervical DRG of CCI rats after 3 and 14 days
(Figure 8). A significantly higher level of IL-6R immuno-
fluorescence was found in the large neurons of lumbar
DRG from the ipsilateral compared with the contralat-
eral side, but no significant differences were found be-
tween the ipsilateral and contralateral medium and small
neurons 3 days after CCI. The level of IL-6R immuno-
fluorescence was significantly decreased in all types of
neurons 14 days after CCI.
Neuronal bodies of all diameters also displayed signifi-
cant increases in IL-6R immunofluorescence in the cer-
vical DRG of the ipsilateral side compared with naive
neuronal bodies. This increased immunostaining in
ipsilateral cervical DRG was found at 3 and 14 days
from CCI. The level was significantly higher in large
and medium-sized neurons in the ipsilateral compared
with the contralateral cervical DRG. By contrast, the
small neurons displayed bilateral elevation of IL-6R
immunostaining after both short and long periods of
survival.
ELISA assessment of interleukin-6 protein in dorsal root
ganglia and plasma
The baseline level of IL-6 protein was significantly
higher in cervical (124.9 ± 8.1 pg/0.1 mg total protein)
than lumbar (75.1 ± 6.0 pg/0.1 mg total protein) DRG of
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Figure 2 Immunofluorescence staining for interleukin (IL)-6. (A-H) Immunofluorescence staining for IL-6 in sections of dorsal root ganglia
(DRG) removed from different groups of rats. Sections of (A) lumbar (L-DRGn) and (B) cervical (C-DRGn) DRG of naive rats. (C,D) Representative
sections of L4 DRG from ipsilateral (L-DRGi) and contralateral (L-DRGc) sides of rats 3 days after unilateral chronic constriction injury (CCI) of the
sciatic nerve (CCI 3D). (E,F) Cervical DRG from the ipsilateral (C-DRGi) and contralateral (C-DRGc) sides of the same rats (G,H) Ipsilateral cervical
(C-DRGi) and lumbar (L-DRGi) DRG 3 days after sham operation. Large neurons (thick arrows), medium and small neurons (thin arrows), satellite
glial cells (arrowheads). The sections were treated with rabbit polyclonal anti-IL-6 antibody and tetramethyl rhodamine isothiocyanate (TRITC)-
conjugated donkey anti-rabbit secondary antibody under identical conditions. Scale bars = 60 μm.
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the naive rats. Thus, the differences in DRG of different
spinal levels should be borne in mind when comparing
results of operated animals. Therefore, the IL-6 protein
levels were normalized to the baseline values of the
naive rats to compare IL-6 alteration in DRG and
plasma of CCI and sham rats.
Compared with DRG of naive rats, increased levels of
IL-6 protein were found bilaterally in both lumbar and
cervical DRG from 1 to 14 days after unilateral CCI of
the sciatic nerve. The levels of IL-6 protein peaked on
day 3, when they were 10 and more than 5 times higher
in ipsilateral and contralateral lumbar DRG, respectively.
These levels declined afterwards, but remained higher
than those of naive DRG (Figure 9).
Significant increases in IL-6 levels were found in ipsilat-
eral lumbar and cervical DRG from sham rats surviving
for 1, 3, and 14 days. The corresponding contralateral
DRG did not display significant elevation of IL-6 protein
compared with naive DRG (Figure 9).
The IL-6 protein levels increased approximately 1.5
and 2 times in the plasma of CCI and sham rats
surviving for 1 and 3 days, respectively. Levels of plasma
IL-6 protein then normalized during the time to the next
survival time points (Figure 10).
Western blot analysis
Western blot analysis showed bilateral increases in IL-6
protein levels in both lumbar (Figure 11A) and cervical
DRG (Figure 11B) of CCI rats compared with DRG of
naive DRG. Densitometry of western blots for total L4-
L5 DRG fractions showed a significant bilateral increase
in IL-6 protein at 1, 3, 7, and 14 days after surgery. At 1
and 3 days after CCI, the levels of IL-6 protein were in-
creased bilaterally by about 6 (L4-L5 DRG) and 5 (C7-
C8 DRG) times in comparison with DRG of the naive
rats. The levels of IL-6 protein remained similarly in-
creased, by more than 3 times, in DRG of both lumbar
and cervical segments at postoperative days 7 and 14.
Compared with naive rats, sham rats had higher levels
of IL-6 protein in both lumbar and cervical DRG re-
moved 1 day after the sham operation. The IL-6 protein
Figure 3 Double immunofluorescence staining for interleukin (IL)-6 and activating transcription factor (ATF)-3 or glutamine synthase
(GS). Representative sections through ipsilateral lumbar DRG illustrating double immunostaining for (A,D) IL-6 and (B) ATF-3, indicating neuronal
bodies with injured axons, and/or (E) GS as a marker of satellite glial cells (SGC). (C) Merged picture shows that increased IL-6 immunostaining
was induced by chronic constriction injury (CCI) not only in ATF-3 positive neurons (thin arrows) but also in ATF-3 free neurons (thick arrows). (F)
Merged picture shows an increase in IL-6 immunofluorescence in SGC (arrowheads) surrounding large neuronal bodies. Sections were cut
through ipsilateral lumbar DRG of rats subjected to unilateral CCI of the sciatic nerve for 3 days. After incubation with mouse monoclonal anti–IL-
6 and rabbit polyclonal anti-ATF-3, the section was covered with affinity-purified secondary antibodies: (A) tetramethyl rhodamine isothiocyanate
(TRITC)-conjugated donkey anti-mouse; (B) fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit. To identify IL-6 upregulation in SGC,
the section was covered with rabbit polyclonal anti–IL-6 antibody and mouse monoclonal anti-GS. Affinity-purified secondary antibodies were
applied: (D) TRITC-conjugated donkey anti-rabbit; (E) FITC-conjugated donkey anti-mouse. Positions of the cell nuclei were detected by staining
with Hoechst 33342. Scale bars: (A–C) 60 μm; (D–F) 40 μm.
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levels in DRG from sham rats surviving for 3 days were
similar to those of naive rats.
In situ hybridization
Neuronal bodies and their SGC displayed no or very
weak signal for IL-6 mRNA in sections of lumbar and
cervical DRG removed from naive rats. Faint staining for
IL-6 mRNA was detected only in the blood vessels of
naive DRG (Figure 12A, Figure 13A). Unilateral CCI of
the sciatic nerve induced conspicuous bilateral elevation
of staining for IL-6 mRNA in both lumbar and cervical
DRG 1, 3, 7, and 14 days after operation. The patterns
and intensities of staining for IL-6 mRNA were very
similar in lumbar and cervical DRG sections for 1 and 3
days and for 7 and 14 days of survival, and hence repre-
sentative illustrations from 3 and 14 days are shown
(Figure 12B–E, Figure 13B,C). In comparison with naive
DRG, an increased intensity for IL-6 mRNA staining
was seen, particularly in neuronal bodies of all sizes and
in the SGC surrounding the large neurons. No detect-
able signal for IL-6 mRNA was found in cells of the
DRG capsule, but there was staining lining the Schwann
cells of nerve fibers inside the DRG.
When the DRG sections were treated for in situ
hybridization under the same conditions, the density of IL-
6 mRNA staining was higher in sections of ipsilateral than
contralateral lumbar DRG for short (1 and 3 days) and long
(7 and 14 days) periods of survival (Figure 14). The intense
staining for IL-6 mRNA in neuronal bodies did not usually
allow staining to be distinguished in the thin layer of the
SGC envelope. This was possible only in some SGC sur-
rounding the large neuronal bodies and mainly in DRG
from sham rats (Figure 12F–I; Figure 13E).
Compared with lumbar DRG, the sections of cervical
DRG from CCI rats had weaker staining for IL-6 mRNA
in neuronal bodies, and therefore the staining of SGC
was highlighted (Figures 13B,C). The density of IL-6
mRNA staining was slightly higher in medium and small
neurons for short (1 and 3 days) than for long (7 and 14
days) periods of survival. No marked differences in IL-6
mRNA staining were seen between ipsilateral and
contralateral cervical DRG (Figure 14).
Figure 4 Double immunofluorescence staining for interleukin (IL)-6 and ED-1 or T-cell receptor (TCR). Representative sections through
ipsilateral lumbar dorsal root ganglia (DRG) illustrate double immunostaining (A,D) for IL-6 and (B) ED-1, indicating invaded macrophages, and/or
(E) TCR, a common marker of T cells. (C,F) Merged pictures show that ED-1+ macrophages and T cells (arrowheads) may contribute to IL-6
protein increase in lumbar DRG after chronic constriction injury (CCI) of the sciatic nerve. Sections were cut through ipsilateral lumbar DRG of rats
subjected to unilateral CCI of the sciatic nerve for 3 days. After incubation with (A,D) rabbit polyclonal anti–IL-6 and (B) mouse monoclonal anti-
ED-1 or (E) anti-TCR, the sections were treated with affinity-purified antibodies: (A,D) tetramethyl rhodamine isothiocyanate (TRITC)-conjugated
donkey anti-rabbit and (B,E) fluorescein isothiocyanate (FITC)-conjugated donkey anti-mouse. Positions of the cell nuclei were detected by
staining with Hoechst 33342. Scale bars: 60 μm.
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In comparison with naive DRG, stronger staining for IL-
6 mRNA was seen in SGC and small neuronal bodies of
both ipsilateral and contralateral lumbar DRG removed
after 3 days from sham rats. Increased staining intensity
was seen in SGC and blood vessels but no neuronal stain-
ing was found in lumbar DRG of rats surviving 14 days
after sham operation (Figure 12F–I). Although at 3 days
after sham operation, the cervical DRG on both sides
displayed increased staining for IL-6 mRNA in blood ves-
sels only, a weak signal was found in SGC when DRG were
removed 14 days after sham operation (Figure 13D–E).
Discussion
IL-6 is a multifunctional cytokine whose increased level
in the nervous system is rapidly and strongly induced by
injury and by pathological and inflammatory stimuli
[28]. A very low level of IL-6 was reported in the periph-
eral nervous system of intact mature animals, but its in-
crease is induced distal to the site of sciatic nerve injury
[29,30] and in the large and medium lumbar DRG neu-
rons [15,31]. A weaker IL-6 induction was found in a
CCI model of neuropathic pain, but it persisted for a
longer time than in a nerve transection model. IL-6
induction in the CCI model was shown to correlate well
with the duration of hypersensitivity [16]. It was
reported that intrathecally administered human recom-
binant IL-6 elicited touch-evoked hyperalgesia in normal
rats [32] and an injection of IL-6 into the rat hind paw
induced dose-dependent mechanical hyperalgesia [33].
These findings suggest that IL-6 may be centrally in-
volved in the cascade of events leading to the develop-
ment of neuropathic pain. However, in addition to
cytokines, upregulation of other immune mediators such
Figure 5 Results from image analysis of interleukin (IL)-6 immunofluorescence intensity in dorsal root ganglia (DRG). Results of
immunofluorescence intensity for IL-6 in lumbar and cervical DRG removed from naive rats and those subjected to chronic constriction injury
(CCI) for short (3 days) and long (14 days) periods of survival. Measurement by an image analysis system was carried out in large, medium, and
small neuronal bodies of ipsilateral (ipsi) and contralateral (contra) DRG. Significant difference (P<0.05) compared with: +baseline level of naive
rats, †value of contralateral counterparts, and #value between 3 and 14 days of survival.
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as chemokines may also increase excitation of the DRG
neurons in reaction to nerve injury [34,35].
Cellular localization of interleukin-6 protein and mRNA in
dorsal root ganglia
In agreement with previous papers [30,36], our results for
immunohistochemical staining and in situ hybridization
show that the primary sensory neurons are significant
sources for enhanced IL-6 in DRG after CCI of the sciatic
nerve. As indicated by ATF-3 staining, increased IL-6 ex-
pression was not limited to neurons with axonal injury
but was also present in all neurons of DRG. In particular,
significant enhancement of IL-6 immunostaining was
clearly visible in large neuronal bodies, with greater en-
hancement in lumbar DRG ipsilateral to CCI than in
contralateral DRG. The neuronal bodies of all sizes in cer-
vical DRG and the medium and small neurons of lumbar
DRG had increased IL-6 immunostaining but without sig-
nificant differences between ipsilateral and contralateral
sides. Double immunostaining showed that SGC, macro-
phages, and T cells may also contribute to the enhanced
level of IL-6 protein in DRG.
Very little or no IL-6 protein or mRNA were detected in
DRG neurons of sham rats, indicating that intraneuronal
occurrence of IL-6 protein and its synthesis is induced by
unilateral CCI of the sciatic nerve. Intraneuronal IL-6
Figure 6 Immunofluorescence staining for interleukin-6 receptor (IL-6R). Representative sections of (A,C,E) lumbar and (B,D,F) cervical
dorsal root ganglia (DRG) incubated for IL-6R immunohistochemical staining. Sections of L4 and C7 DRG removed from (A,B) naive rats and (C–F)
from rats 3 days after chronic constriction injury (CCI) of the sciatic nerve. Immunofluorescence staining for IL-6R was increased in the large (thick
arrows), medium, and small (thin arrows) neurons of lumbar and cervical DRG from both ipsilateral (DRGi) and contralateral (DRGc) sides of CCI
rats compared with naive rats (DRGn). Increased IL-6R immunofluorescence was also present in satellite glial cells (SGC) of lumbar DRG ipsilateral
to CCI (C, arrowhead). The sections were treated with rabbit polyclonal anti-IL-6R antibody and tetramethyl rhodamine isothiocyanate (TRITC)-
conjugated donkey anti-rabbit secondary antibody under identical conditions. Scale bars = 80 μm.
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mRNA and protein have been detected in DRG after vari-
ous types of nerve manipulation [15,31,37]. In contrast to
previous reports of induction of IL-6 mRNA only in the
medium-sized and large lumbar DRG neurons [15,31], we
found distinct increases in signal for IL-6 mRNA in DRG
neurons of all sizes. This discrepancy is possibly due to
the different in situ hybridization methods used, with
radiographic probes being used by Murphy and coworkers
(35S-labeled or 33P-labeled oligonucleotides) but a non-
radioactive method (DIG-labeled probes) in our experi-
ments. An in situ hybridization method with DIG-labeled
probes can be used successfully to detect mRNAs in fro-
zen sections with a sensitivity equal to or better than that
of a radioactive method but with a much higher cellular
resolution [38]. Therefore, an in situ hybridization method
with DIG-labeled probes was used successfully in our ex-
periments to detect IL-6 mRNA in neuronal bodies and
their SGC in frozen DRG sections removed from rats.
It is well-known that SGC are activated by nerve in-
jury, and they may also play a role in the development of
pathological pain [39]. Compared with naive DRG, there
was higher intensity of immunofluorescence for IL-6
and of staining for IL-6 mRNA in SGC of lumbar and
cervical DRG of both sides after CCI or sham operation.
However, it was difficult to distinguish unequivocally be-
tween IL-6 mRNA staining in neuronal bodies and their
SGC of lumbar DRG, because a similar staining intensity
was present in both cell types. Detection of IL-6 mRNA
in SGC was easier in sections of cervical DRG when the
staining density of neuronal bodies was lower than in
lumbar DRG. Moreover, in contrast to neurons, SGC of
both lumbar and cervical DRG removed from sham rats
displayed increased staining for IL-6 mRNA, thus indi-
cating that their activation and resultant synthesis of IL-
6 may occurre only in response to tissue damage during
surgical treatment. These results of activated SGC in
DRG of sham rats correspond with findings of SGC pro-
liferation and activation in response to scarification or
incision of the skin [40,41].
IL-6 acts by binding to IL-6R and activating the gpl30
transducer chain. Although IL-6R expression is limited in
cells of the nervous system [42], we found bilateral in-
creases in IL-6R immunostaining in all neurons of both
lumbar and cervical DRG from CCI rats. However, only
SGC of lumbar DRG ipsilateral to CCI of the sciatic nerve
displayed distinct immunostaining for IL-6R. This indicates
some small differences of IL-6 action in DRG directly asso-
ciated and not associated with injured nerve [43].
Bilateral expression of interleukin-6 protein and mRNA in
dorsal root ganglia after unilateral chronic constriction
injury of the sciatic nerve
Bilateral expression of IL-6 protein and mRNA in DRG
was not unexpected, because there is a growing body of
evidence that unilateral nerve damage results in bilateral
changes in neurochemical and electrophysiological param-
eters in DRG [44-46], including cytokines [18,37,47,48]. It
has been generally accepted that contralateral responses
to unilateral nerve injury are usually qualitatively similar
but smaller in magnitude and have a briefer time course
compared with ipsilateral changes [49]. However, our re-
sults showed that levels of IL-6 protein and mRNA in the
contralateral DRG paralleled those of the ipsilateral DRG,
not only in homonymous but also in heteronymous spinal
cord segments with injured nerve. Bilateral upregulation
of IL-6 in lumbar and cervical DRG after unilateral nerve
injury is comparable with the expression of tumor necro-
sis factor (TNF)-α and IL-10 [50,51]. This indicates that
cytokine upregulations in DRG that are associated or not
Figure 7 Double immunofluorescence staining for interleukin-6 receptor (IL-6R) and glutamine synthase (GS). Representative sections
through lumbar dorsal root ganglia (DRG) incubated (A) with rabbit polyclonal anti-IL-6R and then (B) with mouse monoclonal anti-GS
antibodies. To visualize colocalization, the section was treated with affinity-purified secondary antibodies: tetramethyl rhodamine isothiocyanate
(TRITC)-conjugated donkey anti-rabbit and fluorescein isothiocyanate (FITC)-conjugated donkey anti-mouse. Staining with Hoechst 33342 was
used to detect positions of the cell nuclei. (C) Merged picture shows increased immunofluorescence staining for IL-6R in satellite glial cells (SGC),
indicated by simultaneous immunostaining for GS (arrowheads). Sections were cut through ipsilateral lumbar DRG of rats 3 days after unilateral
chronic constriction injury (CCI) of the sciatic nerve. Scale bars = 40 μm.
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associated with damaged nerve are induced by similar
mechanisms.
The original CCI method using chromic gut [52] is a
widely applied experimental model that induces charac-
teristic signs and symptoms of neuropathic pain found
in humans. However, because chromic gut itself induces
local inflammatory reaction, this original CCI model of
neuropathic pain is not suitable for distinguishing
neuroinflammatory reactions induced by a thread mater-
ial and/or Wallerian degeneration of injured axons
[53,54]. Therefore, we prepared CCI of the sciatic nerve in
our experimental rats using 3-0 sterilized suture (Ethicon)
under aseptic conditions. Thus, the bilateral changes in
IL-6 protein and mRNA in both lumbar and cervical DRG
presented here were largely induced by partial traumatic
nerve injury accompanied by neuroinflammatory response
of Wallerian degeneration.
Possible mechanisms of contralateral signaling were
reviewed by Koltzenburg and coworkers [49], but the
underlying molecular mechanisms and neuroanatomical
pathways linked with bilateral DRG responses to unilat-
eral peripheral nerve injury remain largely unknown.
Figure 8 Results of image analysis of interleukin-6 receptor (IL-6R) immunofluorescence intensity in dorsal root ganglia (DRG). Results
of immunofluorescence intensity for IL-6R in lumbar and cervical DRG removed from naive rats and those subjected to chronic constriction injury
(CCI) for short (3 days) and late (14 days) periods of survival. Measurement by an image analysis system was carried out in large, medium, and
small neuronal bodies of ipsilateral (ipsi) and contralateral (contra) DRG. Significant difference (P<0.05) compared with +baseline level of naive
rats, †value of contralateral counterparts, and #value between 3 and 14 days of survival.
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Two main types of stimuli may be involved in inducing
bilateral changes in IL-6 protein and mRNA in both
lumbar and cervical DRG after unilateral CCI of the sci-
atic nerve. The first type of stimuli could be transferred
by neuronal pathways, for example, through interneu-
rons at the spinal cord and supraspinal levels [55-57].
Moreover, there is a long ascending propriospinal system
linking lumbar and cervical spinal-cord segments. The
so-called long ascending propriospinal neurons are de-
fined as interneurons whose somata are located in the
lumbar spinal-cord segments and whose axons terminate
in cervical segments. These neurons are in an anatomi-
cally appropriate position to participate in coordinat-
ing movements of hind and fore limbs [58]. Changes
in neuronal activity may partially contribute to the in-
duction of IL-6 expression in neurons [59], although
other mechanisms of IL-6 regulation, for example by
systemic factors, can be assumed because DRG do not
contain a complete blood–nerve barrier [60].
These other possible mechanisms inducing IL-6
mRNA and protein in DRG are probably related to pro-
duction of signaling molecules during Wallerian degen-
eration. Experimental findings have suggested that IL-6
is induced in DRG by an injury factor arising from the
nerve stump rather than by interruption of retrograde
axonal transport of signal molecules from target tissues
Figure 9 ELISA of interleukin (IL)-6 protein in dorsal root ganglia (DRG). Levels of IL-6 protein measured by ELISA in the ipsilateral (ipsi-DRG)
and contralateral (contra-DRG) DRG of lumbar (L4-L5) and cervical (C7-C8) spinal segments removed from naive rats and rats after unilateral
chronic constriction injury (CCI) of the sciatic nerve or sham operation. *Significant difference (P<0.05) when the protein levels of individual times
of survival were compared with the baseline level of naive rats.
Figure 10 ELISA of interleukin (IL)-6 protein in plasma. Levels of
IL-6 protein measured by ELISA in plasma of the same animals as for
dorsal root ganglia (DRG). *Significant difference (P<0.05) when the
protein levels for individual times of survival were compared with
the baseline levels of naive rats.
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or distal nerve segments [15,16]. The results from the
current study implicate Wallerian degeneration as one
possible source of the factors inducing bilateral increases
in IL-6 mRNA and protein in both lumbar and cervical
DRG after unilateral CCI performed under aseptic
conditions. The type of signal molecules produced by
Wallerian degeneration can pass through an interrupted
blood–nerve barrier [61,62], thus allowing diffusion of
circulating signal molecules into the microenvironment of
the DRG not associated with the injured nerve. Several
Figure 11 Western blot analysis of interleukin (IL)-6 protein levels. Western blot analysis of IL-6 protein levels in dorsal root ganglia (DRG) at (A)
L4-L5 and (B) C7-C8 from naive rats (0), rats with unilateral chronic constriction injury (CCI) of the sciatic nerve after 1, 3, 7, and 14 days, and rats with sham
surgery after 1 and 3 days. Upper panels illustrate representative western blotting bands of ipsilateral (I) and contralateral (C) DRG from two naive, two CCI,
and two sham rats for each period of survival. Equal loading of proteins was confirmed by α-tubulin staining (Tu). Lower panels show mean density ± SD
of individual IL-6 protein bands in triplicate analysis after normalization to tubulin, with the mean density of the IL-6 bands from naive DRG taken as 1.
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Figure 12 In situ hybridization for interleukin (IL)-6 mRNA in lumbar dorsal root ganglia (DRG). Representative sections of in situ
hybridization for IL-6 mRNA in (A) lumbar DRG (L-DRG) from naive rat, and in (B–I) ipsilateral (L-DRGi) and contralateral (L-DRGc) DRG from (B–E)
rats with chronic constriction injury (CCI) at (B,C) 3 and (D,E) 14 days after surgery, and (F–I) sham-operated rats (F,G) 3 and (H,I) 14 days after
surgery. Staining for IL-6 mRNA was present in blood vessels (black arrows), neuronal bodies of various sizes (white arrows), and satellite glial cells
(SGC; arrowheads). Scale bars = 50 μm.
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candidate molecules have been suggested for signaling from
damaged nerve, including ATP, glutamate, complement or
prostaglandin E2 [63-66]. Some of these signal molecules
are probably produced by damaged tissue during surgical
treatment, as was indicated by induction of IL-6 mRNA
and protein in SGC of DRG removed from sham rats.
ATP, which is suggested to be one of the first media-
tors of tissue damage, acts through ionotropic P2X
receptors and metabotropic P2Y receptors [67]. It has
been shown that the P2X3 receptor of DRG neurons
and the P2X7 receptor expressed in SGC are two major
purinergic receptors participating in neuron–SGC com-
munication. The bodies of excited DRG neurons
release ATP and activate P2X7 receptor, which is ex-
pressed only in SGCs [68-70]. Although it is noteworthy
that P2X7 receptor is associated with inflammatory reac-
tions of SGC in order to induce their sensitivity to ATP,
and that this may significantly contribute to neuropathic
pain [71], it has been shown that activation of P2X3 con-
tributing to mechanical hyperalgesia does not depend on
pro-inflammatory cytokines, including IL-6 [72]. How-
ever, the P2X7 receptor is upregulated in human DRG
and injured nerves obtained from patients with chronic
neuropathic pain. It has been reported that P2X7 re-
ceptor knockout animals did not display mechanical or
thermal hyperalgesia although normal nociceptive pro-
cessing was preserved [73]. However, involvement of the
P2X7 receptor in the regulation of IL-6 is controversial.
It was reported that ATP-induced IL-6 production is not
mediated by P2X7 receptors [74], whereas others found
markedly increased levels of IL-6 in inflamed hind paw
of P2X7-/- mice [73], indicating that this receptor is in-
volved in regulating IL-6 levels. This might be present in
the case of SGC, which, in contrast to DRG neurons,
express both P2X7 [73] and IL-6.
Serum level of interleukin-6 protein after chronic
constriction injury of the sciatic nerve
There are some controversial results illustrating changes
in plasma IL-6 after rat nerve injury and the involvement
Figure 13 In situ hybridization for interleukin (IL)-6 mRNA in cervical dorsal root ganglia (DRG). Representative in situ hybridization
staining for IL-6 mRNA in sections through cervical DRG (C-DRG) from (A) naive rat, (B,C) rat with chronic constriction injury (CCI) at (B) 3 and (C)
14 days after surgery, and sham-operated rat at (D) 3 and (E) 14 days after surgery. Staining for IL-6 mRNA was present in blood vessels (black
arrows), neuronal bodies of various sizes (white arrows), and satellite glial cells (SGC; arrowheads). Scale bars = 50 μm.
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of these changes in neuropathic pain induction. It was
reported that an increase in plasma IL-6 had no effect on
pain [14], whereas other evidence suggested that such an
increase had a hyperalgesic effect [33]. In our experiments,
the plasma IL-6 protein was increased approximately 1.5
and 2 times in rats surviving 1 and 3 days from CCI and
sham operation, respectively. By contrast, the increase in
IL-6 protein in DRG was significantly higher (3 to 10
times), thus suggesting that plasma IL-6 did not contribute
substantially to the increase of the cytokine in DRG. A
decrease in IL-6 to the level seen in naive rats 7 and 14
days after CCI, when mechanical hyperalgesia and thermal
hyperalgesia were measured, indicates that changes in
plasma IL-6 induced by nerve injury do not correlate
exactly with induction and maintenance of neuropathic
pain.
In the context of neuropathic pain, it is important to
mention that pro-inflammatory cytokines, of which IL-6
is the main one, also induce behavioral discomfort or
‘sickness’, not only in response to infection but also after
nerve trauma [75,76]. Although the level of IL-6 protein
in blood plasma has specifically been shown to be corre-
lated with infection-induced sickness [75], its level in
neuropathic pain status is controversial [14,33,77]. The
animals in our experiments were housed under specific
pathogen-free conditions, and behavioral tests were
measured under conditions that would minimize stress
on the animals.
Figure 14 Results of interleukin (IL)-6 mRNA staining density in dorsal root ganglia (DRG). Results of staining density for IL-6 mRNA in
lumbar (L-DRG) and cervical (C-DRG) dorsal root ganglia removed from naive rats (naive) and those subjected to chronic constriction injury (CCI)
for short (3 days) and late (14 days) periods of survival. Measurement by image analysis system was carried out in large, medium, and small
neuronal bodies of ipsilateral (ipsi) and contralateral (contra) DRG. +Significant difference (P<0.05) compared with naive rats.
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The level of plasma IL-6 in both CCI and sham rats
was increased only at 1 and 3 days of survival, and nor-
malized thereafter. A higher level of plasma IL-6 during
the short period of survival corresponds with published
findings [78], and reflects a post-operation reaction that
is probably related to bilateral thermal hyperalgesia in
both hind and fore paws of sham-operated rats.
Our behavioral tests are in accordance with published
results [79] showing that sham surgery without nerve
manipulation is sufficient to induce temporary hyper-
algesia, as also measured by some other authors [80,81].
Bilateral thermal hyperalgesia was identical in both hind
and fore paws of sham rats in our experiments, thus in-
dicating that effects of surgery treatment are adequate to
alter mechanisms of sensory processing in both fore and
hind paws. However, the same pattern of thermal hyper-
algesia was not seen in sham versus CCI rats. To explain
these findings, we believe that the central control struc-
tures may be differently activated after sham and CCI
treatment of animals and thus would have resulted in their
different behavioral reactions to heat stimuli. The sham
operation probably did not activate central control mecha-
nisms, as these are triggered by nerve injury [82-84].
A possible functional involvement of interleukin-6 protein
in dorsal root ganglia associated or not associated with
injured nerve
IL-6 may be critically involved in the cascade of events
after nerve injury leading to the development and main-
tenance of behaviors suggestive of neuropathic pain.
Fundamental evidence as to a role of IL-6 in nociception
and hyperalgesia has been found by direct injection of
IL-6 into experimental animals [14,32]. In addition, IL-6-/-
mice showed reduced heat sensitivity in a hot-plate behav-
ioral test [85]. Our results confirmed the increase in IL-6
mRNA and protein in DRG neurons ipsilateral to CCI for
at least 14 days when hypersensitivity was apparent in the
ipsilateral hind paws [16]. This indicates that continuous
upregulation of IL-6 in DRG associated with injured nerve
is linked to induction of hyperalgesia. Different animal
neuropathic pain models have been established to cover
the diverse etiology and consequently the diverse clinical
manifestation of neuropathic pain, with high validation
and reproducibility. However, they have shortcomings
and limitations that should be taken into consideration.
Principally, the measured alterations in cutaneous sensory
thresholds might be responses to nerve injury rather
than integrated pain-related behavior reactions. Moreover,
because for ethical reasons experimental animals usually
survive only days or weeks, the clinical aspects of neuro-
pathic pain are measured in years [86]. Thus, animal
models are relevant predominantly for testing of induction
of neuropathic pain, and have limited value for simulating
chronic hypersensitivity changes in patients.
Our results from immunohistochemistry, western blot-
ting, and in situ hybridization unequivocally showed an
unexpected IL-6 response in contralateral lumbar and
cervical DRG on both sides, which did not coincide with
behavioral signs of hypersensitivity in corresponding
paw skin. A similar pattern of expression was found for
TNF-α and IL-10 [50,51] suggesting that these changes
in DRG occurring after unilateral CCI may reflect a gen-
eral neuroinflammatory reaction of the nervous system
to injury. Involvement of cytokines upregulated in
remote DRG with neuropathic pain induction is still
unknown, and other experiments are required to eluci-
date this.
Elevation of IL-6 in DRG that are not associated with
injured nerves indicates a possible functional involve-
ment of IL-6 other than that of neuropathic pain induc-
tion. Several lines of evidence have shown that IL-6 is
implicated as a key component in the injury response of
the nervous system. Consistent with our findings for IL-
6, there is evidence that nerve growth factor mRNA is
also increased bilaterally in lumbar and cervical DRG
after unilateral crushing of the sciatic nerve [87]. More-
over, IL-6 plays a role in promoting neuronal survival
[12] and axonal growth by DRG neurons [37]. Thus, IL-
6 upregulation in the primary sensory neurons of DRG
that are not associated with damaged nerve might be
linked with conditioning of the intact neurons to regen-
erate their axons [88,89].
Conclusion
In a rat model of neuropathic pain based on aseptic uni-
lateral CCI of the sciatic nerve, we found that the
contralateral L4-L5 DRG and the cervical DRG on both
sides were not spared from IL-6 response to unilateral
sciatic nerve injury even though these DRG were not
directly linked with the damaged nerve. The increase in
IL-6 protein and mRNA in the ipsilateral lumbar DRG
only was related to (or at least coincided with) behav-
ioral presentations of hyperalgesia in the corresponding
limb.
Although these findings of increased IL-6 protein and
mRNA in DRG associated with damaged nerve may sup-
port a role for IL-6 in developing neuropathic pain, the
finding of IL-6 in DRG not associated with injured nerve
argues against a direct coupling between IL-6 elevation
in DRG and hypersensitivity. The results of our IL-6
study suggest that neuroinflammatory reaction of DRG
to nerve injury is propagated alongside neuroaxis from
lumbar to remote cervical segments. This phenomenon
probably illustrates a general neuroinflammatory reac-
tion of the nervous system to local nerve injury.
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